All Articles on Obesity
How can your neighborhood nudge you toward healthier behavior?Dr. David Arterburn and UW/KPWHRI team go hyperlocal with $2.67-million Moving to Health award from NIDDK on ‘built environment.’
How can we use technology to support patients after bariatric surgery?With funding from the Partnership for Innovation, KPWHRI is evaluating a new technology-based lifestyle program designed by KPWHRI bariatric surgeons.
Bariatric surgery keeps weight off in long termWeight loss persisted for 10 years with Roux-en-Y gastric bypass in Dr. Arterburn’s large multisite study of veterans.
Bariatric surgery may have ‘legacy effect’ on diabetes complicationsDr. Arterburn linked even short-term diabetes remission to less risk for microvascular kidney, eye, and limb diseases
Gastric bypass surgery beats intensive lifestyle and medical intervention for diabetesDr. David Arterburn reflects on CROSSROADS randomized controlled trial of Group Health patients with obesity and type 2 diabetes.
Weight controlled better with bupropion (Wellbutrin) than with other antidepressantsDr. David Arterburn describes his research on Group Health patients’ weight after 2 years on various antidepressants
One antidepressant shown to control weight during 2-year studyResearch at Kaiser Permanente points to bupropion (Wellbutrin) as first choice for overweight and obese patients with depression.
